Refs Why Xatmep? ALL

References: 1. U.S. FDA/CDER. Pharmacy compounding of human drug products under section 503A of the FDCA Guidance. June 2016. 2. Sellers S, Utian WH. Pharmacy compounding primer for physicians. Drugs. 2012;72:2043-2050. 3. Xatmep™ [prescribing information]. Greenwood Village, CO: Silvergate Pharmaceuticals, Inc.; 2018. 4. Data on file, Silvergate Pharmaceuticals, Inc.; 2017.